A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma.
Stone MJ, Sausville EA, Fay JW, Headlee D, Collins RH, Figg WD, Stetler-Stevenson M, Jain V, Jaffe ES, Solomon D, Lush RM, Senderowicz A, Ghetie V, Schindler J, Uhr JW, Vitetta ES.
Stone MJ, et al. Among authors: ghetie v.
Blood. 1996 Aug 15;88(4):1188-97.
Blood. 1996.
PMID: 8695836
Free article.
Clinical Trial.